Sam Brusco, Associate Editor05.09.24
Medtech contract research organization (CRO) RQM+ has named John Potthoff, Ph.D. as its new CEO.
The chief executive transition follows former CEO Margaret Keegan’s announcement of moving out of day-to-day operations to focus on her role as an operating partner with Linden Capital Partners. Margaret will remain on the company’s board.
Dr. Potthoff is a co-founder and former CEO of Elligo Health Research and has been a member of the RQM+ board since 2021. Before Elligo, he was CEO of Theorem Research, which had a significant global medical device and diagnostics business.
He was also the chief operating officer at INC Research.
“During Margaret’s tenure, she completed three acquisitions and made significant progress in creating an end-to-end MedTech CRO at RQM+,” Dr. Potthoff said. “I look forward to building on this remarkable foundation and continuing to drive growth and advance global healthcare through MedTech innovation.”
“I am extremely proud of the RQM+ team's many accomplishments,” added departing CEO Keegan. “While I’ll be stepping away from day-to-day operations, I look forward to continuing to support the company. I believe John is a proven leader and is very knowledgeable about the company and our industry. He is well-positioned to lead and enhance RQM+ to meet the ever-changing MedTech industry needs now and into the future.”
Earlier this year, RQM+ appointed Eric Pauls to the newly-created role of chief customer officer.
The chief executive transition follows former CEO Margaret Keegan’s announcement of moving out of day-to-day operations to focus on her role as an operating partner with Linden Capital Partners. Margaret will remain on the company’s board.
Dr. Potthoff is a co-founder and former CEO of Elligo Health Research and has been a member of the RQM+ board since 2021. Before Elligo, he was CEO of Theorem Research, which had a significant global medical device and diagnostics business.
He was also the chief operating officer at INC Research.
“During Margaret’s tenure, she completed three acquisitions and made significant progress in creating an end-to-end MedTech CRO at RQM+,” Dr. Potthoff said. “I look forward to building on this remarkable foundation and continuing to drive growth and advance global healthcare through MedTech innovation.”
“I am extremely proud of the RQM+ team's many accomplishments,” added departing CEO Keegan. “While I’ll be stepping away from day-to-day operations, I look forward to continuing to support the company. I believe John is a proven leader and is very knowledgeable about the company and our industry. He is well-positioned to lead and enhance RQM+ to meet the ever-changing MedTech industry needs now and into the future.”
Earlier this year, RQM+ appointed Eric Pauls to the newly-created role of chief customer officer.